Found 18 matching trials
Effect of Finerenone in IgA Nephropathy PHASE3 The aim of this trial is to conduct a randomized, multicenter, placebo-cont...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction N/A Finerenone is a new selective nonsteroidal mineral corticoid receptor antag...
Show More Location
Multiple Locations
Learn More & Join Trial
Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial NA This study is testing whether finerenone, when compared to placebo, is a to...
Show More Location
Centre Hospitalier de l'Université de Montréal
Learn More & Join Trial
Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets PHASE1 This study should estimate the dose proportionality of BAY94-8862 IR tablet...
Show More Location
CRS Clinical-Research-Services Mönchengladbach GmbH
Learn More & Join Trial
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study PHASE2 EFFEKTOR is a vanguard, multicenter, phase 2 randomized, double blinded, pl...
Show More Location
UNC Eastowne Kidney Transplant Clinic
Learn More & Join Trial
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) PHASE4 To evaluate the effects of finerenone on vascular stiffness and cardiorenal...
Show More Location
Saga University Hospital
Learn More & Join Trial
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study PHASE2 Diabetic neuropathy is a serious and common complication of diabetes that c...
Show More Location
Steno Diabetes Center Northern Denmark
Learn More & Join Trial
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT PHASE2 The goal of this clinical trial is to evaluate whether Finerenone and Empag...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing
Learn More & Join Trial
FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors PHASE3 Study to demonstrate efficacy of finerenone when compared to placebo in red...
Show More Status
Enrolling By Invitation
Location
Hospital Universitari Germans Trias i Pujol
Learn More & Join Trial
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect PHASE3 CAPTIVATE is an international, multi-centre, Phase III, adaptive, platform,...
Show More Location
The Canberra Hospital
Learn More & Join Trial